Zhejiang University Researcher Advances Knowledge in Multiple Myeloma (Real-World Clinical Outcomes of Pomalidomide-Based and Daratumumab-Based Therapies in Patients with Relapsed/Refractory Multiple Myeloma: A Single-Center Retrospective ...)

Prensa/medios de comunicación: !!!Research

Períododic. 14 2023

Cobertura de los medios

1

Cobertura de los medios

  • NombreZhejiang University Researcher Advances Knowledge in Multiple Myeloma (Real-World Clinical Outcomes of Pomalidomide-Based and Daratumumab-Based Therapies in Patients with Relapsed/Refractory Multiple Myeloma: A Single-Center Retrospective ...)
    Nombre/canal del medio de comunicaciónImmunotherapy Daily
    País/TerritorioEstados Unidos
    Fecha14/12/23
    PersonasYang Yang
Ver todos 1
Ver menos